Market Movers | Winners: QNC, EGHT, FSLY | Losers: CGEM, ALKT, RAPP
A down day for the averages did not stop some stocks from continuing longer-term trends.
Cullinan Therapeutics (CGEM) led the day’s declines, falling 22.2% against a backdrop of modest losses for the major indexes. The S&P 500 returned -0.8%, while the Nasdaq-100 returned -0.9%.
But are Wednesday’s sharpest moves isolated events, or are some part of a larger pattern? The day’s biggest winners and losers offer the first clues.
Wednesday’s Market Winners
The 10 US-listed stocks in the Trefis coverage universe with the highest returns on the last trading day:
| # | Ticker | Company Name | 1-D Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | QNC | Quantum eMotion | 15.3% | -44.8% |
| 2 | EGHT | 8×8 | 15.1% | 16.2% |
| 3 | FSLY | Fastly | 13.7% | 191.3% |
| 4 | MEI | Methode Electronics | 9.7% | 127.2% |
| 5 | ACMR | ACM Research | 6.4% | 104.5% |
| 6 | KVYO | Klaviyo | 5.7% | -48.3% |
| 7 | VICR | Vicor | 5.5% | 158.4% |
| 8 | ALNT | Allient | 5.1% | 111.7% |
| 9 | CRWD | CrowdStrike | 5.0% | 124.0% |
| 10 | AMPL | Amplitude | 4.7% | 18.8% |
Wednesday’s Market Losers
And the 10 US-listed stocks in the Trefis coverage universe with the lowest returns:
| # | Ticker | Company Name | 1-D Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | CGEM | Cullinan Therapeutics | -22.2% | 63.0% |
| 2 | ALKT | Alkami Technology | -19.3% | -36.7% |
| 3 | RAPP | Rapport Therapeutics | -17.7% | 12.5% |
| 4 | VOYG | Voyager Technologies | -16.3% | 20.1% |
| 5 | CTEV | Claritev | -15.0% | -41.4% |
| 6 | CBIO | Crescent Biopharma | -13.7% | 19.6% |
| 7 | IMUX | Immunic | -13.6% | 75.6% |
| 8 | SVIA | Silvia | -13.5% | 14.2% |
| 9 | LXEO | Lexeo Therapeutics | -13.5% | -64.6% |
| 10 | BYND | Beyond Meat | -12.9% | -59.2% |
Some of Wednesday’s moves have been building for weeks.
Vicor (VICR) appears on both the one-day and one-month winners lists. The stock’s one-month return is +49.0%, and it still gained +41.2% over the other sessions in that period. A similar persistence is visible on the downside. Immunic (IMUX) is present on both the one-day and one-month losers lists, with a one-month return of -43.1%. Excluding Wednesday, the stock still lost 34.1% over the prior sessions.
Movers Over The Last Week
Widening the window to five trading days, these are the strongest and weakest names in the Trefis coverage universe:
Winners
| # | Ticker | Company Name | 1-W Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | VICR | Vicor | 54.0% | 158.4% |
| 2 | CYPH | Cypherpunk Technologies | 48.0% | 211.2% |
| 3 | CD | Chaince Digital | 45.1% | -13.9% |
| 4 | GRAL | GRAIL | 44.5% | 26.8% |
| 5 | VKTX | Viking Therapeutics | 41.1% | 18.4% |
| 6 | GEMI | Gemini Space Station | 34.7% | -43.2% |
| 7 | FWDI | Forward Industries | 34.1% | 21.9% |
| 8 | ALAB | Astera Labs | 33.9% | 116.7% |
| 9 | PRTH | Priority Technology | 32.4% | 43.1% |
| 10 | INOD | Innodata | 29.9% | 41.3% |
Losers
| # | Ticker | Company Name | 1-W Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | XENE | Xenon Pharmaceuticals | -35.6% | -18.4% |
| 2 | XNDU | Xanadu Quantum Technologies | -28.9% | n/a |
| 3 | CTEV | Claritev | -25.4% | -41.4% |
| 4 | EVER | EverQuote | -24.5% | -34.7% |
| 5 | GSHD | Goosehead Insurance | -22.9% | -40.9% |
| 6 | ALKT | Alkami Technology | -22.9% | -36.7% |
| 7 | QNST | QuinStreet | -22.4% | -0.6% |
| 8 | RSI | Rush Street Interactive | -20.6% | 5.8% |
| 9 | CLDX | Celldex Therapeutics | -19.6% | 14.6% |
| 10 | PAY | Paymentus | -18.3% | -5.2% |
Movers Over The Last Month
And over the last 21 trading days, the strongest and weakest names in the Trefis coverage universe:
Winners
| # | Ticker | Company Name | 1-M Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | INDP | Indaptus Therapeutics | 225.0% | 29.6% |
| 2 | CYPH | Cypherpunk Technologies | 114.9% | 211.2% |
| 3 | SVIA | Silvia | 87.4% | 14.2% |
| 4 | OKTA | OKTA | 56.8% | 137.5% |
| 5 | SDGR | Schrodinger | 55.7% | 63.5% |
| 6 | VICR | Vicor | 49.0% | 158.4% |
| 7 | NUAI | New Era Energy & Digital | 45.2% | 138.6% |
| 8 | GRAL | GRAIL | 41.7% | 26.8% |
| 9 | FWDI | Forward Industries | 40.7% | 21.9% |
| 10 | INTC | Intel | 40.5% | 232.2% |
Losers
| # | Ticker | Company Name | 1-M Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | ALMS | Alumis | -67.7% | -23.8% |
| 2 | XNDU | Xanadu Quantum Technologies | -49.0% | n/a |
| 3 | IMUX | Immunic | -43.1% | 75.6% |
| 4 | SWMR | Swarmer | -42.8% | n/a |
| 5 | RARE | Ultragenyx Pharmaceutical | -42.1% | -35.3% |
| 6 | ALHC | Alignment Healthcare | -41.5% | -60.2% |
| 7 | GSHD | Goosehead Insurance | -40.4% | -40.9% |
| 8 | XENE | Xenon Pharmaceuticals | -39.6% | -18.4% |
| 9 | FBYD | Falcons Beyond Global | -38.2% | -55.5% |
| 10 | DYN | Dyne Therapeutics | -37.6% | -17.0% |
A large return is information, not an instruction.
The lists of major movers shown earlier are a map of where market attention is focused. A stock that has gained or lost a significant amount is communicating new information about its perceived risk and potential. The disciplined response is not to chase the performance, but to investigate the business behind the ticker. These tables are a starting point for research, not a conclusion.
The next step is never to trade the list; it is to test it. Our Guidance Momentum screen shows which risers have management raising guidance behind them, and our Buy the Dip screen shows which of the fallers still generate the growth and cash that make a recovery plausible.
Today’s Winner Is Tomorrow’s Loser Often Enough
The movers list is the most honest picture of single-stock risk the market prints each day: the same volatility that makes the winners column also fills the losers column, and no one reliably knows which side a stock lands on next.
That is the case for owning a disciplined basket instead of chasing the tape. The Trefis High Quality (HQ) Portfolio holds roughly 30 businesses selected for consistent cash generation, strong margins, and resilient balance sheets, sized and rebalanced with rules. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Watch the movers for information; let the portfolio do the compounding.